Life-Threatening Wunderlich Syndrome Associated with Apixaban and the Complexity of Anticoagulation Management in Bleeding Patients: A Case Report

Authors

  • Sérgio Maltês Cardiology Department. Hospital de Santa Cruz. Centro Hospitalar Lisboa Ocidental. Lisbon.
  • Cristina Carvalho Gouveia Internal Medicine Department. Hospital de São Francisco Xavier. Centro Hospitalar Lisboa Ocidental. Lisbon.
  • Filipa Serrazina Neurology Department. Hospital de Egas Moniz. Centro Hospitalar Lisboa Ocidental. Lisbon.
  • Marta Rebelo Intensive Care Department. Hospital de Egas Moniz. Centro Hospitalar Lisboa Ocidental. Lisbon.

DOI:

https://doi.org/10.20344/amp.16941

Keywords:

Acute Kidney Injury, Anticoagulants/adverse effects, Hemorrage, Kidney Diseases/chemically induced, Rupture, Spontaneous

Abstract

Wunderlich syndrome is a rare and possibly life-threatening haemorrhagic syndrome presenting as spontaneous nontraumatic renal rupture with subcapsular and perinephric haemorrhage. Apixaban, a direct oral anticoagulant recommended in patients with atrial fibrillation, has previously been associated with atraumatic solid organ rupture but, to date, no case of apixaban-related Wunderlich syndrome has been reported. We report a rare case of Wunderlich syndrome associated with apixaban while addressing the difficulties face by clinicians when managing anticoagulation in bleeding patients.

Downloads

Download data is not yet available.

Downloads

Published

2022-07-08

How to Cite

1.
Maltês S, Carvalho Gouveia C, Serrazina F, Rebelo M. Life-Threatening Wunderlich Syndrome Associated with Apixaban and the Complexity of Anticoagulation Management in Bleeding Patients: A Case Report. Acta Med Port [Internet]. 2022 Jul. 8 [cited 2022 Dec. 1];. Available from: https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/16941

Issue

Section

Case Report